PDI 2009 ISDP LAC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Perit Dial Int 27(3): 277-282 2007
© 2007 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gabriel, D. P.
Right arrow Articles by Balbi, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gabriel, D. P.
Right arrow Articles by Balbi, A. L.

Clinical

HIGH VOLUME PERITONEAL DIALYSIS FOR ACUTE RENAL FAILURE

Daniela Ponce Gabriel, Ginivaldo Victor Ribeiro do Nascimento, Jacqueline Teixeira Caramori, Luís Cuadrado Martim, Pasqual Barretti and André Luís Balbi

Department of Internal Medicine, University Hospital, Botucatu School of Medicine, São Paulo State University, São Paulo, Brazil

Correspondence to: D. Ponce Gabriel, Department of Internal Medicine, Hospital das Clínicas da Faculdade de Medicina de Botucatu, Universidade Estadual Paulista - UNESP, Rubião Júnior, P.O. Box 584, CEP 18618-970, São Paulo, Brazil.
dponcegabriel{at}uol.com.br

{diamondsuit} Background: Peritoneal dialysis (PD) is still widely used for acute renal failure (ARF) in developing countries despite concerns about its inadequacy. Continuous PD has been evaluated in ARF by analyzing the resolution of metabolic abnormality and normalization of plasma pH, bicarbonate, and potassium.

{diamondsuit} Methodology: A prospective study was performed on 30 ARF patients who were assigned to high-dose continuous PD (Kt/V = 0.65 per session) via a flexible catheter (Tenckhoff) and automated PD with a cycler. Fluid removal, pH and metabolic control, protein loss, and patient outcome were evaluated.

{diamondsuit} Results: Patients received 236 continuous PD sessions; 76% were admitted to ICUs. APACHE II score was 32.2±8.65. BUN concentrations stabilized after 3 sessions, creatinine after 4, and bicarbonate and pH after 2. Fluid removal was 2.1±0.62 L/day. Creatinine and urea clearances were 15.8±4.16 and 17.3±5.01 mL/minute respectively. Normalized creatinine clearance and urea Kt/V values were 110.6±22.5 L/week/1.73 m2 body surface area and 3.8±0.6 respectively. Solute reduction index was 41%±6.5% per session. Serum albumin values remained stable in spite of considerable protein losses (median 21.7 g/day, interquartile range 9.1-29.8 g/day). Regarding ARF outcome, 23% of patients presented renal function recovery, 13% remained on dialysis after 30 days of follow-up, and 57% died.

{diamondsuit} Conclusion: High-dose continuous PD by flexible catheter and cycler was an effective treatment for ARF. It provided high solute removal, allowing appropriate metabolic and pH control, and adequate dialysis dose and fluid removal. Continuous PD can therefore be considered an alternative to other forms of renal replacement therapy in ARF.

KEY WORDS: KEY WORDS:; Acute renal failure; continuous peritoneal dialysis; Kt/V; treatment.

Received 5 April 2006; accepted 23 November 2006.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2007 by Multimed Inc.